Kimihiro Kawakami

Association of Higher Methotrexate Dose With Lymphoproliferative Disease Onset in Rheumatoid Arthritis Patients

Tomohiro Kameda, Hiroaki Dobashi, Nobuyuki Miyatake et al. · Arthritis Care & Research · 2014 · 93 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Shorter halving time of BCR‐ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic‐phase chronic myeloid leukemia treated with dasatinib: Results of the D‐first study of <scp>K</scp>anto CML study group

Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida et al. · American Journal of Hematology · 2014 · 47 citations

Medicine, Oncology, Pharmacology +13

Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

Yuho Najima, Chikashi Yoshida, Noriyoshi Iriyama et al. · Leukemia Research · 2018 · 36 citations

Life Sciences, Immunology, Oncology +10

Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D‐first study

Noriyoshi Iriyama, Shin Fujisawa, Chikashi Yoshida et al. · American Journal of Hematology · 2015 · 35 citations · Full text

Medicine, Hematology, Oncology +14

Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies

Ryo Ishino, Yumi Kawase, Naoshi Sugimoto et al. · Molecular Therapy · 2020 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +15